Capital Rx Promotes Sara Izadi to Chief Clinical Officer
The Californer/10253425

NEW YORK, Sept. 8, 2023 ~ Today, Capital Rx, the health technology company changing the way prescription drugs are priced and patients are cared for, announced the promotion of Sara Izadi, PharmD to Chief Clinical Officer. Dr. Izadi has been a part of Capital Rx since its early days and has been leading the clinical team and clinical program initiatives since 2018.

In her new role as Chief Clinical Officer, Dr. Izadi will continue to ensure clinical service excellence, oversee quality management functions, and spearhead the development of novel clinical programs to provide the best possible outcomes for Capital Rx's members. She expressed her gratitude for being part of such a successful organization and looks forward to continuing to deliver optimal clinical outcomes for patients while balancing costs for plan sponsors.

More on The Californer

• How Strategic WooCommerce Development and Digital Marketing Helped a Fashion Ecommerce Business Increase Revenue by 3X
• VIV Welcomes Residents to St. Petersburg's EDGE District
• Evocative Joins the Independent Data Centre Network (IDCN) as Primary USA Operator
• California Lemon Law Process Explained By Los Angeles Lemon Law Attorney
• Learn Window Tinting in Los Angeles with the Tint Academy – June 20th & 21st

AJ Loiacono, CEO of Capital Rx praised Dr. Izadi's leadership skills and said that in her expanded role she will further elevate their clinical programs as they progress into the next phase of their organization's growth.

Prior to joining Capital Rx, Dr. Izadi was a Senior Pharmacist and Program Lead at UnitedHealth Group and a Research/Clinical Pharmacist at Cedars-Sinai Medical Center. She holds a Doctor of Pharmacy degree from the University of California – San Francisco.

Capital Rx is proud to have Sara Izadi as their Chief Clinical Officer and looks forward to her continued success in this role.

---

Show All News | Disclaimer | Report Violation